ATTEST-2 study design summary
ATTEST-2 study design summary
  • *
    Single bolus, maximum 25 mg.
  • †
    Number refers to the ITT population in this arm.
  • ‡
    Using a mixed minimisation and randomisation approach.
  • §
    10% bolus and 90% as IV infusion over 60 minutes, maximum 90 mg.

AIS: acute ischaemic stroke; ITT: intention to treat; IV: intravenous; mRS: modified Rankin Scale; NIHSS: National Institutes of Health Stroke Scale; sICH: symptomatic intracerebral haemorrhage.

  1. Muir KW, et al. Lancet Neurol 2024;23:1087–1096 (including supplementary appendix).